Company · CIK 0001408299 · SIC 2833 — Medicinal Chemicals & Botanical Products
Entia Biosciences, Inc. · ERGO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2017 AForm 4 → | Feb 16, 7:19 pm EST | Marvin S Hausman M.D.Chairman, CSTO, Director | 3,211,170 | $0.175 | $325,705 | 10,188,900 | — | plan? |
| Feb 14, 2017 AForm 4 → | Feb 16, 6:01 pm EST | Elliot SheltonSecretary, Director | 450,000 | — | — | 976,250 | — | plan? |
| Feb 14, 2017 AForm 4 → | Feb 16, 5:57 pm EST | Carl J JohnsonPresident and CEO, Director | 850,000 | — | — | 850,000 | — | plan? |
| Feb 14, 2017 AForm 4 → | Feb 16, 5:55 pm EST | Timothy A TimminsEVP, COO and CFO | 800,000 | — | — | 800,000 | — | plan? |
| May 8, 2015 AForm 4 → | Dec 9, 12:21 pm EST | Cheuk Ho Tam10% Owner | 1,025,462 | $0.01 | $10,255 | 1,521,228 | — | plan? late |
| May 8, 2015 AForm 4 → | Dec 9, 12:20 pm EST | Wah On Edward Wong10% Owner | 1,025,462 | $0.01 | $10,255 | 1,521,228 | — | plan? late |
| May 8, 2015 AForm 4 → | Dec 9, 12:19 pm EST | Delta Group Investments Ltd10% Owner | 2,050,923 | $0.01 | $20,509 | 3,042,455 | — | plan? late |
| May 8, 2015 AForm 4 → | Dec 9, 12:17 pm EST | ANKA CAPITAL LTD10% Owner | 2,050,923 | $0.01 | $20,509 | 3,042,455 | — | plan? late |
| Apr 24, 2015 AForm 4 → | Apr 28, 3:57 pm EDT | Philip A SobolDirector | 200,000 | $0.20 | $40,000 | 281,667 | — | plan? |
| Apr 24, 2015 AForm 4 → | Apr 28, 3:54 pm EDT | Elliot SheltonSecretary, Director | 200,000 | $0.20 | $40,000 | 326,250 | — | plan? |
| Apr 24, 2015 AForm 4 → | Apr 28, 11:06 am EDT | Marvin S Hausman M.D.CEO, President, Acting CFO, Director, 10% Owner | 600,000 | $0.20 | $120,000 | 4,757,200 | — | plan? |
| Apr 24, 2015 AForm 4 → | Apr 28, 11:02 am EDT | Devin D. AndresChief Operating Officer | 550,000 | $0.20 | $110,000 | 1,171,671 | — | plan? |
| Oct 24, 2014 GForm 5 → | Feb 17, 2015, 8:15 pm EST | Marvin S Hausman M.D.Pres., CEO, Acting CFO, Director, 10% Owner | 43,600 | $0.30 | $13,080 | 4,157,200 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2016 PForm 4 → | Dec 6, 9:57 pm EST | Marvin S Hausman M.D.Chairman,Chief Sci/Tech Offc | 40,000 | — | — | 40,000 | — | |
| May 20, 2016 PForm 4 → | May 24, 4:56 pm EDT | Carl J JohnsonPresident & CEO, Director | 25,000 | $0.125 | $3,125 | 25,000 | — | |
| Sep 29, 2014 AForm 5 → | Feb 17, 2015, 8:15 pm EST | Marvin S Hausman M.D.Pres., CEO, Acting CFO, Director, 10% Owner | 175,000 | $0.40 | $70,000 | 175,000 | — | |
| Sep 29, 2014 AForm 5 → | Feb 17, 2015, 8:15 pm EST | Devin D. AndresCOO, Vice Pres. | 47,999 | $0.40 | $19,200 | 47,999 | — |